Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

about

Parkinson's Disease: From Pathogenesis to Pharmacogenomics Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice

P2860

Q37729129-FBF2BC07-5DE6-45AC-85D8-6C021EC628D0 Q41108882-7B7AA16C-B074-45BC-91B9-1C5841374379 Q58730704-C373747A-9FD9-4BAE-8B95-13A7792FDC15

P2860

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Item

http://www.wikidata.org/entity/Q38926644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Membrane transporters as media ...... ics: implications for disease.

@en

type

Item

label

Membrane transporters as media ...... ics: implications for disease.

@en

prefLabel

Membrane transporters as media ...... ics: implications for disease.

@en

P1476

Membrane transporters as media ...... ics: implications for disease.

@en

P2093

Ali Salahpour

http://www.w3.org/2001/XMLSchema#string

Kelly M Lohr

http://www.w3.org/2001/XMLSchema#string

Shababa T Masoud

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease: clinical features and diagnosis

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse

Plasma membrane monoamine transporters: structure, regulation and function

LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool

The synaptic vesicle cycle

LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Expression cloning of a reserpine-sensitive vesicular monoamine transporter

Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry

P304

20-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJN.13357

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gary W Miller

P577

2016-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27520881

http://www.w3.org/2001/XMLSchema#string

P932

5209277

http://www.w3.org/2001/XMLSchema#string

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

about

P2860

P2860

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932